OncoMed Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

OncoMed Pharmaceuticals Ownership

Who owns OncoMed Pharmaceuticals?

.

Was OncoMed Pharmaceuticals formerly PE-backed?

Yes. OncoMed Pharmaceuticals was formerly owned by 2 private investors.

OncoMed Pharmaceuticals Business Overview

Where is OncoMed Pharmaceuticals headquartered?

OncoMed Pharmaceuticals is headquartered in Redwood City, California.

What is OncoMed Pharmaceuticals’ revenue?

OncoMed Pharmaceuticals disclosed revenue of 44M USD for 2018 and 38M USD for 2017.

How many employees does OncoMed Pharmaceuticals have?

OncoMed Pharmaceuticals has 22 employees.

What sector is OncoMed Pharmaceuticals in?

OncoMed Pharmaceuticals is a life science company.

When was OncoMed Pharmaceuticals founded?

OncoMed Pharmaceuticals was founded in 2004.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

OncoMed Pharmaceuticals, Inc.

800 Chesapeake Drive,
Redwood City, California 94063
United States,
(650) 995-8200
www.oncomed.com

OncoMed Pharmaceuticals, Inc. is a clinical-stage company that discovers and develops novel therapeutics targeting cancer stem cells, the cells believed to be capable of driving tumor growth, recurrence and metastases. OncoMed Pharmaceuticals, Inc. was founded in 2004 and is based in Redwood City, California.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.